ABYCX | AMFAX | ABYCX / AMFAX | |
Total Expense Ratio | 2.79 | 1.70 | 164% |
Annual Report Gross Expense Ratio | 2.85 | 1.82 | 157% |
Fund Existence | 10 years | 15 years | - |
Gain YTD | -5.894 | -17.674 | 33% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 2500 | 2500 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.48B | 1.38B | 179% |
Annual Yield % from dividends | 0.98 | 1.55 | 63% |
Returns for 1 year | -12.96 | -28.09 | 46% |
Returns for 3 years | -13.35 | -39.03 | 34% |
Returns for 5 years | 2.98 | -11.74 | -25% |
Returns for 10 years | N/A | -19.02 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FACTX | 46.96 | 0.27 | +0.58% |
Fidelity Advisor Health Care M | |||
MTODX | 21.24 | 0.03 | +0.16% |
NYLI Income Builder Class R6 | |||
TBCIX | 190.20 | -0.15 | -0.08% |
T. Rowe Price Blue Chip Growth I | |||
ODMCX | 10.53 | -0.03 | -0.28% |
JPMorgan SMID Cap Equity C | |||
SPSAX | 18.36 | -0.10 | -0.54% |
Sterling Capital Behav Sm Cp Val Eq A |